Near Patient Molecular Solution Market 2018: Competitive Strategies, Pricing Strategy, Target Audience
Near patient
molecular solution, also called point-of-care diagnosis, is a
technology that helps diagnose and monitor health at the convenience
of the patient. There are various innovations in healthcare such as
basic health monitoring smartphone apps, wearable devices, and
biosensors, which provide ease to patient in monitoring their health.
The motive is to provide patients with easy access to testing
solutions, with quick turnaround time and accurate results as opposed
to that offered by conventional lab-based tests.
Increasing incidence
of diseases such as cardiac disorders and diabetes in developing
countries, growing preference for home-based point-of-care devices,
advancements in technology, and wide availability of easy to use
devices are spurring growth of the near patient molecular solution
market. According to the institute for Health Metrics and Evaluation
(IHME), the number of deaths due to cardiovascular diseases worldwide
increased by 41% between 1990 and 2013, from 12.3 million to 17.3
million deaths. South Asia experienced the largest increase in total
deaths, with 1.8 million more deaths in 2013 than in 1990—an
alarming increase of 97%.
Request
Sample Copy Of This Business
Report:
Due to increasing
demand for point-of-care diagnosis, manufacturing companies are
focusing on developing technologies that provide quick and accurate
results, with small learning curve. However, shortage of skilled
staff in using these devices is expected to restrain the growth of
near patient molecular solution market to a certain extent.
Near patient
molecular solution market taxonomy
On the basis of
technology, the near patient molecular solution market is segmented
as follows:
PCR based: Idylla is
a real-time PCR-based molecular diagnostic system designed in such a
way that physicians have fast access to highly reliable clinical
molecular diagnostic information. Treatments become more targeted to
individual patient through personalized medicine.
Genetic Sequencing
based: Platforms are available that enables genetic sequencing and
analysis of DNA data at point of care with high accuracy. Rapid DNA
analysis is expected to gain traction in the near future.
Hybridization based:
Peptide nucleic acid (PNA) molecular beacon probe is used to quantify
16SrRNA of specific populations in RNA extract of environmental
samples.
On the basis of
application, the global near patient molecular solution market is
segmented as infectious diseases testing kits, pregnancy and
fertility kits, hematology testing kits, urinalysis testing kits, and
glucose monitoring kits. Infectious disease kits are further
sub-segmented into tuberculosis, human immunodeficiency virus (HIV),
hepatitis, and malaria.
Quick turnaround
times of Near Patient Molecular Solutions a boon for Hospitals and
Private Clinics
End users of near
patient molecular solution or POC devices include hospitals,
homecare, research laboratories and diagnostic laboratories. Use of
near patient molecular solutions provides fast turnaround times for
physicians at outpatient care facilities
Download
the PDF brochure:
Global players
involved in near patient molecular solution market
Major companies
operating in the global molecular diagnostics include Abbott
Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific
Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex
Corp., and GenMark Diagnostics. Integration of advanced technologies
in their product offerings is the major focus of companies competing
in near patient molecular solution market. Abbott’s i-STAT Alinity
handheld blood testing platform received CE mark in November 2016.
Siemens Healthineers acquired Conworx Technology to flesh out its
point-of-care informatics capabilities in November 2016. This highly
lucrative market is expected to witness fast growth in the near
future, fueled by increasing R&D activities by major players in
order to differentiate their offerings.
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
Visit
our news Website: https://www.coherentwire.com
Comments
Post a Comment